NASDAQ: CTMX       Cytomx Thera
Last Price Today's Change   Day's Range   Trading Volume
8.24   -0.62 (7.00%)  8.02 - 9.24  480,935


Avg Volume (4 weeks):894,863
4 Weeks Range:8.02 - 15.44
4 Weeks Price Volatility (%):
52 Weeks Range:3.595 - 15.44
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4034  1698  304  2914 

Top 10 Active Counters
 CETX 2.94+1.993 
 VISL 0.352+0.058 
 DGLY 2.37+1.25 
 AVP 5.60-0.05 
 AESE 4.796+2.346 
 PFE 35.19-3.00 
 AABA 19.630.00 
 TGE 22.39+0.81 
 NCLH 17.052+1.392 
 UAL 29.56+1.52 
Partners & Brokers